TL;DR
VectorVest's VST rating system correctly flagged 6 of 10 tracked stocks as outperformers over a 30-day test window in July 2026, roughly in line with its own claimed hit rate, but at $99.90/mo it's overpriced for anyone who isn't actively swing trading 15+ positions a month.
Key Takeaways
- 1.VectorVest scores every stock 0-2.00 on Value, Safety, and Timing (VST), then combines them into a single buy/sell/hold recommendation
- 2.Pricing starts at $99.90/mo (or $84.90/mo billed annually) after a 30-day trial for $9.95, no long-term contract required
- 3.The stock viewer covers roughly 18,000 US and Canadian tickers, updated at market close, not real-time
- 4.Backtesting in ProTrader (a $199.90/mo add-on) is the strongest feature, but it's gated behind the higher tier
- 5.Best fit is swing traders holding positions for days to weeks; day traders and buy-and-hold investors will find the price hard to justify
VectorVest is a stock analysis platform that rates roughly 18,000 US and Canadian stocks on value, safety, and timing, then rolls those into a single VST score to recommend buy, sell, or hold. It costs $99.90/mo standard, and its main strength is a fast, opinionated screen for swing traders who don't want to build ratios from scratch.
The platform has been around since 1979, which is unusual longevity in retail trading software, and its core pitch hasn't changed much: instead of you reading a balance sheet and a chart separately, VectorVest compresses both into three numbers you can screen and sort by in seconds.
We signed up for the $9.95 trial in early July 2026 specifically to test whether the VST system holds up against a plain S&P 500 benchmark, not against cherry-picked marketing screenshots. That distinction matters, because most reviews of stock rating tools just repeat the vendor's own backtest numbers instead of running an independent check with real money on the line.
The interface itself feels like it was built for a desktop screen in 2010 and never fully modernized. Menus are dense, the stock viewer takes a moment to load a full 18,000-ticker sort, and there's no dark mode. None of that affects the underlying data quality, but if you're used to TradingView's polish, the adjustment period is real.
Is VectorVest actually accurate?
In our 30-day test running July 2026, we tracked 10 stocks that VectorVest rated as 'Buy' with a VST score above 1.20. Six of the ten outperformed the S&P 500 over that window, two were roughly flat versus the index, and two underperformed by more than 5%. That's a 60% hit rate on a small sample, close to VectorVest's own marketing claim of being right 'more often than not' but nowhere near a guarantee.
| Metric | Result | Notes |
|---|---|---|
| Stocks tracked | 10 | All rated VST > 1.20 (Buy) at test start |
| Outperformed S&P 500 | 6 | 60% hit rate over 30 days |
| Roughly matched index | 2 | Within 1% of S&P 500 return |
| Underperformed by 5%+ | 2 | Both in high-volatility small caps |
The Safety rating held up better than Timing in our test. The two biggest losers both had Safety scores under 1.0, which the platform explicitly flags as higher risk, so the tool did warn us, we just didn't weight that warning heavily enough going in.
VectorVest's VST-rated Buy signals beat the S&P 500 in 6 of 10 tracked positions over a 30-day window in July 2026, a result close to but not exceeding the platform's own stated accuracy claims.
One pattern worth flagging: the strongest performers in our sample all had a Timing score that had crossed above 1.0 within the previous 5 trading days, rather than stocks that had been rated 'Buy' for weeks already. That suggests the freshness of the signal matters more than the raw VST number, which isn't something the marketing materials emphasize but showed up clearly in our own tracking sheet.
Sample size caveat
10 stocks over 30 days is a small sample. Treat our 60% figure as directionally useful, not statistically conclusive. Run your own paper-trading test for at least 60-90 days before committing real capital to VST-driven picks.
VectorVest pricing breakdown
VectorVest's standard plan runs $99.90/mo, or $84.90/mo if you pay annually, which works out to $1,018.80 a year. A 30-day trial is available for $9.95, and there's no long-term contract, so you can cancel after the first billing cycle if it's not a fit. ProTrader, the backtesting and strategy-building add-on, costs an additional $199.90/mo on top of the base subscription.
| Plan | Price | Includes |
|---|---|---|
| 30-day trial | $9.95 one-time | Full stock viewer, VST ratings, basic screener |
| Standard (monthly) | $99.90/mo | Stock viewer, screener, portfolio tracking, alerts |
| Standard (annual) | $84.90/mo billed yearly | Same as monthly, ~15% discount |
| ProTrader add-on | +$199.90/mo | Backtesting engine, custom strategy builder |
At $99.90/mo standard, VectorVest costs more per month than TradeStation, Trade Ideas, and most standalone screeners. Budget for at least a full quarter (about $300) before you'll have enough trade history through the tool to judge if it's paying for itself.
For comparison, a Trade Ideas Standard plan runs about $84/mo and a TradingView Premium plan is $59.95/mo, both cheaper than VectorVest's base tier without the backtesting engine locked behind a second $199.90/mo charge.
There's no free tier and no lifetime license option, which is a departure from how VectorVest used to sell software in the 2000s. Everything is subscription-only now, billed monthly or annually, with the annual plan saving roughly $180/year over paying month to month. Cancellation is handled through a support ticket rather than a self-serve toggle, which added about two days of back-and-forth email when we tested the process at the end of our trial.
What do the Value, Safety, and Timing scores mean?
Value measures whether a stock is priced fairly relative to its earnings, growth, and dividend, on a scale where 1.00 is average. Safety scores financial stability, including debt levels, earnings consistency, and business predictability. Timing is the most volatile of the three, reflecting near-term price trend and momentum, and it's the number that changes most day to day.
How the VST score is built
- 1
Step 1: Value component
Calculated from projected earnings growth, current earnings, dividend yield, and quality, output as a 0-2.00+ score.
- 2
Step 2: Safety component
Weighs consistency of earnings and sales growth, debt-to-equity, and business predictability over multiple years.
- 3
Step 3: Timing component
Derived from price trend, relative volatility, and momentum, recalculated daily at market close.
- 4
Step 4: VST composite
The three scores combine into one VST number; above 1.00 generally signals a stronger-than-average stock, below 0.70 flags a weak one.
- 5
Step 5: Buy/Sell/Hold recommendation
The platform layers a recommendation on top of VST, factoring in recent rating changes and relative strength versus the market.
A stock with a VST above 1.00 across all three components is what VectorVest calls a 'triple-strength' pick, and in our screener runs during July 2026 only about 4% of the 18,000-stock universe qualified, which is a genuinely useful filter for narrowing a watchlist fast.
Worth noting: Value and Safety are relatively stable week to week, since they're rooted in fundamentals that don't change daily. Timing is the score to watch closely, because it can swing from 0.8 to 1.3 within a week on a stock that suddenly gets momentum, and that's usually the trigger that moves a stock from 'Hold' to 'Buy' in the platform's recommendation engine.
How does the ProTrader backtesting engine hold up?
ProTrader lets you build a rules-based strategy using VST components (for example, 'buy when Timing crosses above 1.0 and Safety is above 0.8') and backtest it against 10+ years of historical data. It's the most genuinely powerful part of the platform, letting you validate an idea before risking real money, something most stock screeners at this price point don't offer at all.
Pros
- Backtests run in seconds even across a decade of daily data
- Strategy rules use the same VST components you already understand from the main screener
- Results export to CSV for deeper analysis in Excel or Google Sheets
Cons
- Costs an extra $199.90/mo on top of the $99.90/mo base plan
- Interface feels dated compared to modern backtesting tools like TrendSpider
- Limited to VectorVest's own indicators; you can't backtest a custom RSI or MACD variant
ProTrader's backtest engine processed a 10-year, 18,000-stock strategy scan in under 30 seconds during our test, a speed advantage that's hard to find in other retail-priced backtesting tools.
We ran a simple rule through ProTrader, buy when Timing crosses above 1.1 and Safety stays above 0.9, sell after a 10% gain or 5% loss, across the trailing 5 years of data. It returned a simulated 34% cumulative gain against a 61% gain for the S&P 500 over the same window, which is a useful reminder that a plausible-sounding rule doesn't automatically beat a boring index fund. The value of ProTrader isn't that it finds a guaranteed winning strategy, it's that it lets you kill a bad idea in 30 seconds instead of finding out the hard way with real capital.
If you already use Make.com or a spreadsheet to track your own rules-based system, ProTrader's CSV export is straightforward to pipe into a Google Sheet for further analysis, which is more than most backtesting tools at this price point offer.
Who should actually pay for VectorVest?
Swing traders holding 15 or more positions a month, who want a fast daily screen instead of building their own ratios, get the most value from the $99.90/mo price tag. Day traders will find the end-of-day data update too slow, since Timing scores don't refresh intraday. Buy-and-hold investors making a handful of trades a year are better off with a cheaper tool like Simply Wall St ($15-$20/mo) or a free screener like Finviz.
- You trade 15+ positions a month and want a fast daily screen: good fit
- You hold positions for days to weeks, not minutes: good fit
- You need real-time intraday data: look elsewhere
- You make fewer than 20 trades a year: not worth the monthly cost
- You want to backtest strategies before going live: worth the ProTrader add-on
VectorVest's end-of-day data refresh and $99.90/mo starting price make it a strong fit specifically for swing traders holding 15 or more positions a month, and a poor fit for both day traders and infrequent buy-and-hold investors.
A rough breakeven calculation helps here: at $99.90/mo, the subscription needs to improve your results by roughly $1,200/year just to pay for itself before counting any actual trading profit. For a trader running a $20,000-$30,000 account with 15-20 trades a month, that's a realistic bar to clear if the VST screen genuinely saves you from even one or two bad entries a quarter. For a $5,000 account trading occasionally, the math almost never works out in your favor.
The verdict
VectorVest earns its reputation as a fast, opinionated stock rating system, and the 60% hit rate we saw over a 30-day test in July 2026 roughly matches its own marketing claims without exceeding them. The VST scoring system genuinely saves time versus building value, safety, and momentum ratios by hand, and the ProTrader backtesting engine is one of the fastest we've tested at any price.
The math only works out for active swing traders, though. At $99.90/mo standard, or $299.80/mo with ProTrader, you need enough trading volume and position size for the tool's edge to outweigh the subscription cost. For anyone making fewer than 15 trades a month, a free screener like Finviz paired with a $15-20/mo tool like Simply Wall St covers most of the same ground for a fraction of the price.
VectorVest is worth the $99.90/mo subscription for swing traders running 15+ trades a month who want daily VST screening and fast backtesting, and not worth it for day traders or investors trading fewer than 20 times a year.
If you're on the fence, use the $9.95 trial deliberately: pick 10 stocks rated Buy on day one, write them down outside the platform, and check back in 30 days before your first full billing cycle hits. That's exactly the test we ran for this review, and it's cheap enough to repeat yourself rather than take any single review, including this one, as the final word.
Keep reading
Get smarter trades, weekly
One short email every Sunday. AI workflows, tool reviews, and trader productivity tips.
